|
|
|
2011 International Dose-Response Society Awards The International Dose-Response Society is proud to announce the recipients of the annual awards for Outstanding Leadership, Outstanding Career Achievement and Outstanding New Investigator. These awards are presented to individuals in each category who have made outstanding contributions to the field of Dose Response. The awards committee selecting the recipients was Barbara Callahan, University Research; Helmut Hirsch, University at Albany; Ken Mundt, Environ. This year’s awards go to, Jerry Milton Cuttler DSc, PEng, for Outstanding Career Achievement and Marc A. Nascarella, Ph.D. for Outstanding New Investigator. Congratulations to all.
Dr. Cuttler received his BASc-Eng degree (1964) in engineering physics from the University of Toronto and his MSc and DSc degrees (1967 1971) in nuclear sciences and engineering from the Israel Institute of Technology. Until 1974, he managed a radiation detector company. At Atomic Energy of Canada Limited, he led the design and procurement of the reactor control, safety systems and radiation monitoring instrumentation for the first CANDU-6 reactors, the four-reactor Pickering-B station and the four-reactor Bruce-B station. He was engineering manager of AECL’s Bruce-B Project, resident engineering manager in Romania, engineering manager district heating reactors, manager of services to the eight-reactor Pickering station, engineering integration manager of the CANDU-9 Project and manager of technical services including Y2K support to 28 reactors. Dr. Cuttler has been an active member of Professional Engineers Ontario, Canadian Nuclear Society (president 1995-1996), American Nuclear Society, American Physical Society, Canadian Nuclear Association, Health Physics Society, Canadian Radiation Protection Association and the International Dose-Response Society. He has written hundreds of technical reports for nuclear stations, tens of conferences papers and articles for peer-reviewed journals. Starting in 2000, he provided services to Ontario Power Generation for returning Pickering Unit-4 to service and extending the life of the Pickering-B station, to AECL for completing reactors to supply radioisotopes for diagnostic scanning, to Bruce Power for restarting reactors 1/2 and extending the Bruce-B reactor lives for 30 years. Since 1995, Dr. Cuttler has been assessing the health effects of ionizing radiation and drawing international attention to radiation hormesis. He presented tens of papers at many conferences pointing out that low exposures are stimulating for curing infections, extending life and reducing the incidences of cancer and congenital malformations. He organized adaptive response sessions at nuclear energy conferences, inviting renowned radiobiologists to present remarkable evidence. He has urged many oncologists to use total-body low-dose radiation in cancer therapy. He has intervened with regulators with submissions that identify beneficial effects following low doses and debunk the LNT assumption. He arranged presentations by world specialists in low dose at hospitals, universities, nuclear centers and societies. He continues to communicate positive low dose information and fight politicized radiation scares on the Internet and at professional and social clubs.
Dr. Marc A. Nascarella is a toxicologist at Gradient (Cambridge, MA) and specializes in comprehensive chemical evaluations for use in human health risk assessments, product safety evaluations, and litigation support. He is also active in Gradient’s Nanotoxicology Practice where he writes quarterly articles for various trade publications, and has recently served as a Guest Editor of a Dose-Response special issue on nanomaterials. Dr. Nascarella has previously served in a number of academic research centers, professional scientific organizations, government agencies, and the active-duty military. Dr. Nascarella holds an academic appointment as an Adjunct Assistant Professor at the University of Massachusetts Amherst, where he has lectured on environmental health topics, and collaborates with an interdisciplinary dose-response research group. His current research is focused on evaluating high-throughput screening assays to better characterize response in the low-dose zone. These investigations have included evaluations of pharmaceuticals (e.g., antineoplastic and antimicrobial agents), suspected chemical mutagens, and nanomaterials. Dr. Nascarella is an author on over 65 scientific publications and presentations, dealing mostly with quantitative dose-response assessment. Recently, he presented a methodology to evaluate biphasic dose-responses at a National Academy of Sciences risk assessment symposium. Dr. Nascarella’s research has been recognized with awards from the Society of Toxicology’s Risk Assessment Specialty Section, the Colgate-Palmolive/Society of Toxicology Awards Committee, the Entomological Society of America, and the Society for Risk Analysis’ Dose-Response Specialty Group. Dr. Nascarella earned a B.S. (cum laude) from Norwich University where he currently serves on the Board of Fellows for the School of Mathematics and Science. He also earned an M.S. and Ph.D. in the Department of Public Health’s toxicology program at the University of Massachusetts Amherst (Advisor Dr. E.J. Calabrese), and has post-graduate training in immunotoxicology at Texas Tech University/Health Sciences Center (Advisor Dr. S.M. Presley). Dr. Nascarella is a member of the International Dose-Response Society, Sigma Xi, Society for Risk Analysis, Society of Toxicology, and the American Association for the Advancement of Science. |
|
Home | About Us | Membership | Journal | Annual Conference | The Low-Dose | Site Map | Contact |
Jerry Milton Cuttler DSc, PEng
Marc A. Nascarella, Ph.D.